# Merz Therapeutics

> Merz Therapeutics is a VC fund backing Health Care and Therapeutics. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Frankfurt, Germany
- Total investments: 2
- Last investment: Oct 2024
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/merz-therapeutics/?originalSubdomain=de
- Website: https://www.merztherapeutics.com

Merz Therapeutics is a VC fund in Frankfurt focused on Health Care and Therapeutics. Merz Therapeutics is dedicated to improving the lives of patients around the world with its relentless research, development, and culture of innovation. Merz Therapeutics strives to serve unmet patient needs and realize better outcomes.

## Contacts

5 contacts available for Merz Therapeutics. Shizune tracks 3 team members at Merz Therapeutics. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/merz-therapeutics?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Medical Device | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Corporate Round | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Stefan Brinkmann | CEO | 1 | https://shizune.co/investors/profile/stefan-brinkmann |
| Dan Staner | President, Region Europe | 0 | https://shizune.co/investors/profile/dan-staner |
| Stefan König | Chief Executive Officer | 0 | https://shizune.co/investors/profile/stefan-k%C3%B6nig |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Vensica Medical | Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates. | $11M | Venture - Series Unknown | Oct 28, 2024 |  |
| Vensica Medical | Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates. | $3M | Corporate Round | Feb 07, 2022 |  |

2 of 2 investments shown.

## Co-investors
- [Israel Biotech Fund](https://shizune.co/investors/profile/israel-biotechfund) — VC Fund, 1 deal together
- [Laborie Medical Technologies](https://shizune.co/investors/profile/laborie-medical-technologies) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Info Edge](https://shizune.co/investors/profile/info-edge) — VC Fund
- [Vector](https://shizune.co/investors/profile/vector-inc-) — VC Fund
- [Akatsuki Games Inc.](https://shizune.co/investors/profile/akatsuki-3) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Medical Device Investors in Middle East](https://shizune.co/investors/medical-device-investors-middle-east)
- [Medical Device VC Funds in Middle East](https://shizune.co/investors/medical-device-vc-funds-middle-east)
- [Medical Device Investors in Israel](https://shizune.co/investors/medical-device-investors-israel)
- [Medical Device VC Funds in Israel](https://shizune.co/investors/medical-device-vc-funds-israel)

## FAQ

### What does Merz Therapeutics invest in?

Merz Therapeutics invests primarily in Health Care, Therapeutics and Medical Device startups, most often at Corporate Round and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Merz Therapeutics?

Public channels for Merz Therapeutics include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Merz Therapeutics?

The team at Merz Therapeutics includes Stefan Brinkmann (CEO), Dan Staner (President, Region Europe) and Stefan König (Chief Executive Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co